Search

Amy Lim Phones & Addresses

  • San Francisco, CA

Work

Company: villa group real estate Address: San Francisco, CA Phones: (415) 317-4470

Skills

real estate agent • marketing • negotiations • staging • seller • buyer representation. • marketing • Short Sale and REO

Specialities

REO / Bank Owned • Short sales • Residential sales • Luxury homes • First time home buyers • Distressed properties • Relocation

Professional Records

Real Estate Brokers

Amy Lim Photo 1

Amy Lim, San Francisco CA Agent

View page
Specialties:
REO / Bank Owned
Short sales
Residential sales
Luxury homes
First time home buyers
Distressed properties
Relocation
Work:
villa group real estate
San Francisco, CA
(415) 317-4470 (Phone)
Client type:
Home Buyers
Home Sellers
Property type:
Single Family Home
Condo/Townhome
Multi-family
Skills:
real estate agent
marketing
negotiations
staging
seller
buyer representation.
marketing
Short Sale and REO
About:
Most of my business are repeat client and referral . I always help my Seller get the possible highest price and buyers the best possible price. I always listen to my client and give them my useful information to help them make their decision.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Amy R. Lim
Sv Albany Square LLC
7345 Pebble Bch Dr, Richmond, CA 94530
Amy Lim
Juice ! LLC
Personal Brand Consulting
3381 21 St, San Francisco, CA 94110

Publications

Us Patents

Compositions For Microencapsulation Of Antigens For Use As Vaccines

View page
US Patent:
6913767, Jul 5, 2005
Filed:
Apr 30, 1997
Appl. No.:
08/846933
Inventors:
Jeffrey L. Cleland - San Carlos CA, US
Amy Lim - San Bruno CA, US
Michael Frank Powell - San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K051/00
A61K039/00
A61K039/38
A61K009/22
A61M036/14
US Classification:
424468, 424 111, 424 117, 424 129, 424 153, 424 157, 4241841, 4242781, 424400, 424408, 424417, 424418, 424420, 424425, 424428, 424450, 424469, 424472, 424490, 424491
Abstract:
Methods and compositions are provided for the encapsulation of antigens in PLGA microspheres for use as vaccines. Such microspheres can also contain adjuvants. Mixtures of microspheres are provided which release antigen at desired intervals to provide boosts with antigen.

Purification Of Anti-C-Met Antibodies

View page
US Patent:
20130129718, May 23, 2013
Filed:
Nov 20, 2012
Appl. No.:
13/681980
Inventors:
Arick Michael Brown - Pacifica CA, US
Glen Scott Giese - Belmont CA, US
Judy Fay-Chen Hsii - Redwood City CA, US
Amy Lim - Palo Alto CA, US
Josefine Persson - Half Moon Bay CA, US
Asha Nandini Radhamohan - Mountain View CA, US
Maricel Rodriguez - South San Francisco CA, US
Assignee:
GENENTECH, INC. - South San Francisco CA
International Classification:
C07K 1/14
C07K 1/22
A61K 45/06
C07K 1/34
A61K 39/395
C07K 1/18
C07K 16/32
C07K 1/36
US Classification:
4241331, 5303877, 5303873, 4241381, 435375
Abstract:
Provided herein are methods of purifying anti-c-met antibodies, compositions and pharmaceutical formulations comprising purified anti-c-met antibodies, and methods of using the same.

Process For Recovering Purified, Oxidized, Renatured Recombinant Interleukin-2 From Microorganisms

View page
US Patent:
51625075, Nov 10, 1992
Filed:
Sep 12, 1989
Appl. No.:
7/406365
Inventors:
Sidney N. Wolfe - El Cerrito CA
Glenn J. Dorin - San Rafael CA
John T. Davis - Berkeley CA
Flint Smith - Gardon Grove CA
Amy Lim - Hercules CA
Robert Weissburg - Oakland CA
Assignee:
Cetus Corporation - Emeryville CA
International Classification:
C07K 300
C07K 312
US Classification:
530412
Abstract:
A process for recovering highly pure, recombinant IL-2 from transformed microorganisms in which the cells are disrupted; impure recombinant IL-2 is isolated in the form of refractile bodies from the disruptate; the impure IL-2 is dissolved and denatured with at least 6M guanidine hydrochloride containing a reducing agent; the reduced IL-2 is precipitated and resolubilized; the reduced solubilized IL-2 therein is oxidized by a controlled oxidation; the oxidized IL-2 is refolded by reducing the concentration of guanidine hydrochloride in the solution; and the oxidized, refolded IL-2 is further purified by ion exchange chromatography or hydrophobic interaction chromatography and ion exchange chromatography.

Methods And Compositions For Microencapsulation Of Adjuvants

View page
US Patent:
56436050, Jul 1, 1997
Filed:
Jun 2, 1995
Appl. No.:
8/460363
Inventors:
Jeffrey L. Cleland - San Carlos CA
Amy Lim - San Bruno CA
Michael Frank Powell - San Francisco CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 950
US Classification:
424489
Abstract:
Methods and compositions are provided for the encapsulation of adjuvants in PLGA microspheres for use as vaccines. Mixtures of microspheres are provided which release adjuvant at desired intervals to provide boosts with adjuvant.

Method For Regeneration Of An Overload Chromatography Column

View page
US Patent:
20220203347, Jun 30, 2022
Filed:
Dec 3, 2021
Appl. No.:
17/542138
Inventors:
- South San Francisco CA, US
Donna F. Quicho - San Francisco CA, US
Jason A. Brown - San Ramon CA, US
Josefine K. Persson - Half Moon Bay CA, US
Amy Lim - Palo Alto CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
B01J 49/53
B01J 41/20
B01J 49/07
B01J 49/57
C07K 1/18
B01J 49/06
B01J 39/26
B01D 15/36
B01D 15/20
B01D 15/42
B01D 15/38
Abstract:
The present invention provides methods for cleaning or regenerating a chromatography material for reuse. The methods of the invention can be used for cleaning or regenerating ion exchange chromatography columns for reuse in the large-scale manufacture of multiple polypeptide products where the ion exchange chromatography column in used in overload mode.

Assembly Of Bispecific Antibodies

View page
US Patent:
20200317820, Oct 8, 2020
Filed:
Mar 16, 2020
Appl. No.:
16/820660
Inventors:
- South San Francisco CA, US
Amy LIM - Palo Alto CA, US
Josefine PERSSON - Half Moon Bay CA, US
Justin SCHEER - Half Moon Bay CA, US
Ambrose WILLIAMS - Redwood City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/46
Abstract:
Described herein are methods for the efficient production of a heteromultimeric protein, such as a bispecific antibody. Heteromultimeric proteins may be capable of specifically binding to more than one target molecule or different epitopes on a single target molecule. The methods modulate parameters to improve assembly of the heteromultimeric proteins at higher yield and efficiency than otherwise possible. Also described are compositions comprising a hinge-containing polypeptide, such as a half-antibody.

Purification Of Anti-C-Met Antibodies

View page
US Patent:
20190202919, Jul 4, 2019
Filed:
Jun 27, 2018
Appl. No.:
16/020231
Inventors:
- South San Francisco CA, US
Arick M. BROWN - Pacifica CA, US
Glen S. GIESE - Belmont CA, US
Judy Fay-Chen HSII - Redwood City CA, US
Amy LIM - Palo Alto CA, US
Josefine PERSSON - Half Moon Bay CA, US
Asha N. RADHAMOHAN - Mountain View CA, US
Maricel RODRIGUEZ - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/28
C07K 16/32
C07K 1/22
C07K 16/06
A61K 45/06
A61K 39/395
C07K 1/14
C07K 1/18
C07K 1/34
C07K 1/36
Abstract:
Provided herein are methods of purifying anti-c-met antibodies, compositions, and pharmaceutical formulations comprising purified anti-c-met antibodies, and methods of using the same.

Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same

View page
US Patent:
20190056399, Feb 21, 2019
Filed:
Jul 24, 2018
Appl. No.:
16/044360
Inventors:
- South San Francisco CA, US
Liliana T. Yee - San Francisco CA, US
Amy Lim - Palo Alto CA, US
Chris B. Fong - San Leandro CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 33/573
C12N 9/90
C07K 1/22
C07K 16/40
C12N 9/02
A61K 38/00
Abstract:
The present invention provides methods for producing disulfide oxidoreductase A (DsbA) and disulfide oxidoreductase C (DsbC) polypeptides at very high levels of purity. Also provided are ultrapure DsbA and DsbC and methods of using same, e.g., for use in immunoassays to show removal of DsbA and DsbC from biologics produced in bacteria.
Amy Lim from San Francisco, CA, age ~28 Get Report